scholarly journals Cardiovascular Complications and Mortality After Diabetes Diagnosis for South Asian and Chinese Patients

Diabetes Care ◽  
2013 ◽  
Vol 36 (9) ◽  
pp. 2670-2676 ◽  
Author(s):  
Baiju R. Shah ◽  
J. Charles Victor ◽  
Maria Chiu ◽  
Jack V. Tu ◽  
Sonia S. Anand ◽  
...  
2013 ◽  
Vol 45 (3) ◽  
pp. 256-260 ◽  
Author(s):  
E.J. Bakker ◽  
T.M. Valentijn ◽  
S.E. Hoeks ◽  
K.M. van de Luijtgaarden ◽  
F.W. Leebeek ◽  
...  

BMJ Open ◽  
2017 ◽  
Vol 7 (7) ◽  
pp. e015005 ◽  
Author(s):  
Komil N Sarwar ◽  
Phoebe Cliff ◽  
Ponnusamy Saravanan ◽  
Kamlesh Khunti ◽  
Krishnarajah Nirantharakumar ◽  
...  

1984 ◽  
Vol 53 (1) ◽  
pp. 47-58 ◽  
Author(s):  
M. Hanefeld ◽  
C. Hora ◽  
J. Schulze ◽  
G. Rothe ◽  
U. Barthel ◽  
...  

2016 ◽  
Vol 13 (2) ◽  
pp. 17-23
Author(s):  
O D Ostroumova ◽  
A I Kochetkov ◽  
M V Lopukhina

The article discusses the factors that increase the arterial stiffness: the blood pressure, atherosclerosis, smoking, diabetes, age. Given evidence that pulse wave velocity and a number of other indicators that reflect the state of the vascular wall, are markers for increased risk of cardiovascular complications and mortality. The influence of antihypertensive drugs of different groups on the stiffness of the vascular wall, with particular attention paid to the effects of drugs from group of diuretics. We discuss possible mechanisms of the influence of indapamide retard on the elastic properties of vessels. It is emphasized that the influence on the stiffness of the arteries of different antigipertenzivny medicines, even belong to the same class, is different, due to differences in pharmacokinetic properties.


2021 ◽  
Vol 97 (2) ◽  
pp. 16-22
Author(s):  
Zarema R. Khismatullina ◽  
Ksenia M. Koreshkova

An increased risk of cardiovascular events has now been identified in patients with psoriatic arthritis. The chronic immune-mediated inflammation underlying psoriatic arthritis (PA) leads to the development of dyslipidemia, atherosclerosis and its complications, in particular, a high risk of cardiovascular complications. For PA, dyslipidemias are most characteristic, manifested by an increased level of low and very low density lipoproteins, triglycerides and total cholesterol, which correlates with the activity of the disease. The literature review studied the pathogenesis of dyslipidemias and vascular wall lesions in psoriatic arthritis, analyzed the literature on cardiovascular complications and mortality among patients with PA, studied the issues of total cardiovascular risk, presented the results of numerous clinical studies that allow PA to be considered a disease associated with increased the risk of cardiovascular complications. Considering the role of proinflammatory cytokines in the pathogenesis of psoriatic arthritis, early detection of endothelial lesions represents the most promising direction in the prevention of cardiovascular diseases, which are the main cause of mortality in this group of patients.


Heart ◽  
2021 ◽  
pp. heartjnl-2021-320047
Author(s):  
Tom Norris ◽  
Cameron Razieh ◽  
Francesco Zaccardi ◽  
Thomas Yates ◽  
Nazrul Islam ◽  
...  

ObjectiveUsing a large national database of people hospitalised with COVID-19, we investigated the contribution of cardio-metabolic conditions, multi-morbidity and ethnicity on the risk of in-hospital cardiovascular complications and death.MethodsA multicentre, prospective cohort study in 302 UK healthcare facilities of adults hospitalised with COVID-19 between 6 February 2020 and 16 March 2021. Logistic models were used to explore associations between baseline patient ethnicity, cardiometabolic conditions and multimorbidity (0, 1, 2, >2 conditions), and in-hospital cardiovascular complications (heart failure, arrhythmia, cardiac ischaemia, cardiac arrest, coagulation complications, stroke), renal injury and death.ResultsOf 65 624 patients hospitalised with COVID-19, 44 598 (68.0%) reported at least one cardiometabolic condition on admission. Cardiovascular/renal complications or death occurred in 24 609 (38.0%) patients. Baseline cardiometabolic conditions were independently associated with increased odds of in-hospital complications and this risk increased in the presence of cardiometabolic multimorbidity. For example, compared with having no cardiometabolic conditions, 1, 2 or ≥3 conditions was associated with 1.46 (95% CI 1.39 to 1.54), 2.04 (95% CI 1.93 to 2.15) and 3.10 (95% CI 2.92 to 3.29) times higher odds of any cardiovascular/renal complication, respectively. A similar pattern was observed for all-cause death. Compared with the white group, the South Asian (OR 1.19, 95% CI 1.10 to 1.29) and black (OR 1.53 to 95% CI 1.37 to 1.72) ethnic groups had higher risk of any cardiovascular/renal complication.ConclusionsIn hospitalised patients with COVID-19, cardiovascular complications or death impacts just under half of all patients, with the highest risk in those of South Asian or Black ethnicity and in patients with cardiometabolic multimorbidity.


Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1489-P
Author(s):  
TUMADER KHOUJA ◽  
RACHEL G. MILLER ◽  
PAUL A. MOORE ◽  
TREVOR J. ORCHARD ◽  
TINA COSTACOU

Sign in / Sign up

Export Citation Format

Share Document